Healthequity Inc (HQY) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lessened its holdings in shares of Healthequity Inc (NASDAQ:HQY) by 0.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 706,050 shares of the company’s stock after selling 1,658 shares during the quarter. Victory Capital Management Inc.’s holdings in Healthequity were worth $52,234,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Legacy Financial Advisors Inc. bought a new stake in shares of Healthequity in the 4th quarter valued at approximately $28,000. MERIAN GLOBAL INVESTORS UK Ltd acquired a new position in shares of Healthequity during the fourth quarter worth approximately $28,000. Duncker Streett & Co. Inc. acquired a new position in shares of Healthequity during the fourth quarter worth approximately $30,000. Financial Gravity Wealth Inc. acquired a new position in shares of Healthequity during the first quarter worth approximately $45,000. Finally, Quantamental Technologies LLC lifted its holdings in shares of Healthequity by 5,683.3% during the first quarter. Quantamental Technologies LLC now owns 694 shares of the company’s stock worth $51,000 after buying an additional 682 shares during the last quarter. 95.19% of the stock is currently owned by institutional investors.

Healthequity stock traded up $1.20 during mid-day trading on Tuesday, hitting $68.90. 4,506 shares of the company were exchanged, compared to its average volume of 873,932. Healthequity Inc has a 1-year low of $50.29 and a 1-year high of $101.58. The firm has a market capitalization of $4.23 billion, a P/E ratio of 72.59, a P/E/G ratio of 2.98 and a beta of 1.62.



Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Monday, March 18th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.06. Healthequity had a return on equity of 13.59% and a net margin of 25.73%. The firm had revenue of $75.78 million during the quarter, compared to analyst estimates of $74.28 million. During the same period in the prior year, the company posted $0.09 earnings per share. The business’s revenue for the quarter was up 25.4% compared to the same quarter last year. On average, sell-side analysts forecast that Healthequity Inc will post 0.94 EPS for the current fiscal year.

A number of brokerages have recently commented on HQY. Cantor Fitzgerald upped their price target on Healthequity from $83.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, March 19th. BidaskClub lowered Healthequity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 30th. Citigroup restated a “buy” rating on shares of Healthequity in a research note on Friday. Bank of America upped their target price on Healthequity from $82.00 to $83.00 and gave the company a “neutral” rating in a research note on Tuesday, March 19th. Finally, Zacks Investment Research lowered Healthequity from a “hold” rating to a “sell” rating in a research note on Wednesday, February 27th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Healthequity currently has a consensus rating of “Buy” and an average target price of $88.33.

In other news, EVP Delano Ladd sold 6,875 shares of the stock in a transaction on Wednesday, February 20th. The stock was sold at an average price of $78.00, for a total transaction of $536,250.00. Following the sale, the executive vice president now owns 14,340 shares in the company, valued at $1,118,520. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction on Wednesday, February 20th. The stock was sold at an average price of $77.87, for a total value of $311,480.00. Following the sale, the vice president now owns 74,000 shares in the company, valued at approximately $5,762,380. The disclosure for this sale can be found here. Insiders have sold 18,875 shares of company stock valued at $1,451,250 over the last quarter. Corporate insiders own 4.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Healthequity Inc (HQY) Shares Sold by Victory Capital Management Inc.” was originally reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://dakotafinancialnews.com/2019/05/14/healthequity-inc-hqy-shares-sold-by-victory-capital-management-inc.html.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Article: Understanding debt-to-equity ratio in fundamental analysis

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.